HCPCS Code J0702: Injection of Betamethasone Acetate (3 mg) and Betamethasone Sodium Phosphate (3 mg)

Learn about HCPCS Code J0702 for betamethasone injection, billing rules, documentation, treatment uses for arthritis, inflammation, and pain management.

Use Code

## **What is the HCPCS code J0702?** HCPCS code J0702 refers to the injection of a combination corticosteroid medication: betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg. This code is used for billing the administration of this injectable drug, commonly prescribed to reduce inflammation and manage symptoms in various inflammatory conditions such as rheumatoid arthritis, bursitis, tendinitis, ulcerative colitis, systemic lupus erythematosus, severe asthma, and other complications associated with arthritis. The medication helps control pain and swelling, improving patients' mobility and comfort. It is widely used across dermatology, orthopedic surgeon practices, and primary care for treating moderate to severe inflammatory conditions that may not respond adequately to NSAIDs or other treatment options. One unit of J0702 typically represents 6 mg total (3 mg each of betamethasone acetate and betamethasone sodium phosphate). Proper coding depends on the exact administered dose. Some formulations may be labeled as injection betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg, or 3 mg and betamethasone sodium phosphate 3 mg, depending on packaging. This injection is categorized under "Drugs Administered Other than Oral Method" and "Drugs Administered by Injection." Reimbursement rates vary depending on the payer but hover around $7 to $8 per unit on average. This corticosteroid injection is also used to treat allergic reactions, joint inflammation, and conditions requiring reduction of immune responses. In rare cases, risks like tendon rupture or infection may occur, so the doctor must carefully assess and monitor patients.

## **J0702 documentation requirements** The documentation requirements for HCPCS code J0702 (Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg) include the following key elements to ensure proper billing and reimbursement: - The exact dosage of the injection administered must be clearly documented, such as 3 mg and betamethasone sodium phosphate 3 mg. - The patient's diagnosis and the medical rationale for using J0702 should be included. - Relevant treatment notes explaining the use of this medication for inflammatory conditions like rheumatoid arthritis, osteoarthritis, or systemic lupus erythematosus. - Documentation should avoid common errors, such as incorrect units reporting or missing key information in the medical record. - It’s important to differentiate this as an HCPCS code, not a CPT code. - Accurate and thorough documentation is crucial to prevent claims denials and support insurance compliance, especially when using steroids in office procedure settings. These guidelines help ensure accurate coding, proper reimbursement, and compliance with payer requirements. Including these details in the medical record is essential for any claims involving J0702.

## **J0702 billing requirements** The billing requirements for HCPCS code J0702 (injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg) include these key points: - J0702 is an HCPCS code (not CPT) used for billing administration of this specific injectable corticosteroid combination. - One unit of J0702 represents 6 mg total of the medication (3 mg each component). Billing must reflect the exact dosage administered by reporting the appropriate number of units (e.g., 1 unit for 6 mg, two units for 12 mg). - Accurate documentation supporting the billed units must be maintained, including dosage, patient diagnosis, and medical necessity. - Claims should follow payer-specific guidelines and be submitted with proper modifiers when applicable. For example, JZ modifier if zero drug amount is discarded (no wastage), or JW for drug wastage if applicable per CMS guidelines. - J0702 generally involves moderate-level medical decision-making and may require more detailed documentation than lower-level codes. - The code is typically used in settings such as a doctor's office, urgent care, or outpatient clinics. - Reimbursement and fee schedules vary by payer and geographic location, with Medicare rates near $7.86 per unit on average in 2025. - Avoid common billing errors like reporting incorrect units or misclassifying J0702 as a CPT code to prevent claim denials.

## **Other relevant codes** Some of the related codes include: - **J0171**: Injection, adrenaline/epinephrine, 0.1 mg - **J0585**: Injection, onabotulinumtoxin A, 1 unit - **J0588**: Injection, incobotulinumtoxin A, 1 unit - **J0701 and J0703**: Other related betamethasone injection codes (close variants of J0702) - **J0775**: Injection, collagenase, Clostridium histolyticum, 0.01 mg - **J1020, J1030, J1040**: Injection, methylprednisolone acetate, at 20 mg, 40 mg, and 80 mg doses, respectively - **J1100**: Injection, dexamethasone sodium phosphate, 1 mg - **J3300, J3301, J3302**: Injection, triamcinolone acetonide or triamcinolone diacetate, per mg doses These codes represent various corticosteroids, botulinum toxin injections, and other injectable drugs used in similar inflammatory, orthopedic, or dermatologic contexts as J0702. Providers may use these depending on the specific medication and dosing required for the patient's condition.

Frequently asked questions

Betamethasone acetate is a corticosteroid medication used to reduce inflammation and alleviate symptoms in various conditions such as allergic reactions, arthritis, skin diseases, and certain endocrine disorders. It is commonly administered via injection to treat joint pain, tendinitis, bursitis, and other inflammatory conditions by suppressing immune response and decreasing swelling.

The HCPCS J code for betamethasone sodium phosphate injection is J0701, which covers betamethasone sodium phosphate administered via injection, typically used to treat inflammatory and allergic conditions.

Cortisone injections are often coded under HCPCS code J1100, which represents the injection of dexamethasone sodium phosphate, a corticosteroid closely related to cortisone. For cortisone itself, codes such as J1100 or J1120 (for dexamethasone acetate) are used depending on the specific corticosteroid formulation and dosage administered. It’s important to verify the exact corticosteroid product when selecting the HCPCS code.